Pulmonology

Advanced Support: Oxygen, Ventilation, and Looking Ahead

At a Glance

In advanced COPD, treatment is tailored to whether the main problem is low oxygen, high carbon dioxide, or over-inflated lungs. Prescribed oxygen, non-invasive ventilation, lung volume reduction, transplant evaluation, and palliative support may help selected patients after specialist assessment.

When COPD reaches an advanced stage, the focus of your care shifts toward specialized technologies and procedures that support your breathing and heart. These interventions are tailored to your specific clinical needs—whether your primary challenge is low oxygen, high carbon dioxide, or severely over-inflated lungs ^[1]^[2]^[3].

Long-Term Oxygen Therapy (LTOT)

Oxygen is a powerful medicine that, when used correctly, can help you live longer and protect your heart from strain ^[1]. However, a survival benefit from LTOT is established mainly for carefully confirmed severe chronic resting hypoxemia measured while you are clinically stable (not simply one reading during an exacerbation) ^[1]. If you only have exertional or nocturnal desaturation, your expected benefit and prescription will be different ^[4]^[5].

Safe Oxygen Management

Duration: For patients prescribed continuous oxygen, it must typically be used for at least 15 to 18 hours per day to improve survival ^[6]. Using it only “as needed” for shortness of breath does not provide the same long-term protection ^[7].
Targets: Never adjust your oxygen flow rate without clinical instructions. Your clinician will provide an individualized target ^[8]. Too much oxygen in susceptible patients can worsen ventilation-perfusion mismatch and the Haldane effect, leading to a dangerous buildup of carbon dioxide (hypercapnia) ^[9]^[10].
Fire Safety: Oxygen vigorously accelerates fires. Never smoke, allow smoking, or use open flames (like candles or gas stoves) near your oxygen equipment.

Non-Invasive Ventilation (NIV/BiPAP)

Some people with advanced COPD struggle more with getting carbon dioxide out than getting oxygen in. However, chronic NIV is not for every person with advanced COPD. It is considered for selected patients with confirmed persistent chronic hypercapnia after appropriate assessment (which may include evaluation for sleep-disordered breathing) ^[2]^[11].

An NIV machine (often called a BiPAP) uses two different pressures delivered through a mask to help your lungs “wash out” extra CO2 while you sleep ^[12]. This requires specialist fitting and monitoring, but for selected patients, it can reduce hospital readmissions and improve quality of life ^[13]^[14].

Assessing Your Outlook: The BODE Index

To help you and your doctor evaluate your overall clinical condition, a multidimensional prognostic tool called the BODE Index is often used ^[15]^[16]. It evaluates four key areas:

B (Body Mass): Your Body Mass Index (BMI). Maintaining a healthy weight is crucial; being underweight increases risk ^[17].
O (Obstruction): Your FEV1 score from your breathing tests.
D (Dyspnea): How much shortness of breath you feel during daily activities.
E (Exercise): How far you can walk in six minutes.

The BODE index is associated primarily with mortality risk ^[16]^[18]. It is not a rigid prediction of your personal future, but it helps guide discussions about advance care planning and treatment options.

Advanced Surgical and Interventional Options

For those with severe emphysema, advanced procedures may be an option ^[19]. Evaluation for a transplant or surgery should not wait until you have “exhausted all other treatments” or suffered life-threatening respiratory failure; referral timing varies by specialist center.

Lung Volume Reduction

When emphysema causes parts of the lung to become “trapped air” pockets, they make it harder for your healthy lung tissue to work.

Bronchoscopic Valves: Tiny one-way valves can be placed in your airways to deflate the most damaged areas ^[3]^[20]. This requires careful assessment of collateral ventilation and carries a risk of pneumothorax.
Surgical Reduction (LVRS): In some cases, a surgeon may remove the most damaged parts of the lung to allow the remaining tissue to function better ^[21]^[22].

Lung Transplantation

A lung transplant is a major life-changing surgery carrying significant risks and requiring lifelong immunosuppression ^[22]. Evaluation for a transplant is highly individualized and must take place at a specialized center ^[23]^[24].

A complete care plan should also include discussions about symptom-focused supportive and palliative care. Palliative care is not giving up; it is an extra layer of support designed to improve your quality of life, ease symptoms, and assist with advance care planning.

Common questions in this guide

Who may benefit from long-term oxygen therapy for COPD?

Long-term oxygen therapy is mainly shown to help people with severe, chronic low blood oxygen levels measured while they are clinically stable. A low oxygen reading during an exacerbation alone may not establish a long-term need. People whose oxygen drops only with activity or during sleep may have different goals and prescriptions.

How long each day should I use prescribed oxygen?

When continuous oxygen is prescribed, it is typically used for at least 15 to 18 hours each day to provide the intended long-term benefit. Use it exactly as directed, and do not change the flow rate on your own.

Can too much oxygen be harmful in advanced COPD?

Yes. In some people with COPD, excessive oxygen can worsen ventilation problems and cause carbon dioxide to build up, a condition called hypercapnia. Follow your individualized oxygen target and contact your clinician rather than increasing the flow yourself.

When is BiPAP or NIV used for COPD?

NIV, often delivered as BiPAP through a mask, may be considered for selected people with confirmed, persistent high carbon dioxide levels. A specialist usually checks for other contributors, including sleep-related breathing disorders, and monitors the fit and response. It is not automatically needed for everyone with advanced COPD.

What does the BODE index show?

The BODE index combines body mass index, the amount of airflow limitation on breathing tests, breathlessness, and six-minute walking distance. It is associated mainly with mortality risk and helps guide conversations about treatment and future planning. It does not predict one person’s future with certainty.

What procedures may be considered for severe emphysema?

Selected people with severe emphysema may be evaluated for endobronchial valves, lung volume reduction surgery, or lung transplantation. These options require specialized testing and have important risks, including a collapsed lung with valves and lifelong immune-suppressing medicines after transplant. Supportive and palliative care can also improve symptoms and quality of life.

What safety rules are important when using home oxygen?

Oxygen makes fires start and spread more easily. Never smoke, allow anyone to smoke, or use open flames such as candles or gas stoves near oxygen equipment. Follow your equipment supplier’s safety instructions and ask your care team about safe equipment placement.

Curated prompts to bring to your next appointment.

1.What were my latest arterial blood gas (ABG) results, and do they show stable resting hypoxemia that qualifies for long-term oxygen?
2.Can we calculate my BODE index together so I can understand my clinical risk and what I can work on improving (like my walking distance)?
3.Am I a candidate for endobronchial valves or lung volume reduction, and do I need a special CT scan to check for 'collateral ventilation'?
4.Since I'm on continuous oxygen, how many hours a day should I be wearing it to get the most long-term benefit?
5.If my oxygen saturation target is 88-92%, what is the risk of turning my oxygen flow higher than you've prescribed?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Long-term oxygen therapy improves survival mainly for people with severe chronic resting hypoxemia confirmed while clinically stable, and continuous prescriptions are typically used at least 15 to 18 hours daily.
Oxygen flow rates and saturation targets must be individualized because excessive oxygen can worsen carbon dioxide retention in susceptible people.
NIV or BiPAP may help selected patients with persistent chronic hypercapnia after specialist assessment.
The BODE index combines BMI, FEV1, breathlessness, and six-minute walk distance to help discuss mortality risk and care planning, not to predict an individual’s future exactly.
People with severe emphysema may be evaluated for endobronchial valves, lung volume reduction surgery, or transplant, while palliative care can support symptoms and quality of life.

References (24)

1
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.
Jacobs SS, Krishnan JA, Lederer DJ, et al.
American journal of respiratory and critical care medicine 2020; (202(10)):e121-e141 doi:10.1164/rccm.202009-3608ST.
PMID: 33185464
2
Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.
Macrea M, Oczkowski S, Rochwerg B, et al.
American journal of respiratory and critical care medicine 2020; (202(4)):e74-e87 doi:10.1164/rccm.202006-2382ST.
PMID: 32795139
3
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).
Kemp SV, Slebos DJ, Kirk A, et al.
American journal of respiratory and critical care medicine 2017; (196(12)):1535-1543 doi:10.1164/rccm.201707-1327OC.
PMID: 28885054
4
Thoracic Society of Australia and New Zealand clinical practice guideline on adult home oxygen therapy.
McDonald CF, Serginson J, AlShareef S, et al.
Respirology (Carlton, Vic.) 2024; (29(9)):765-784 doi:10.1111/resp.14793.
PMID: 39009413
5
Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward.
Ekström M, Ringbaek T
International journal of chronic obstructive pulmonary disease 2018; (13()):231-235 doi:10.2147/COPD.S148673.
PMID: 29386891
6
Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.
Lacasse Y, Bernard S, Sériès F, et al.
BMC pulmonary medicine 2017; (17(1)):8 doi:10.1186/s12890-016-0343-9.
PMID: 28069009
7
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
, Albert RK, Au DH, et al.
The New England journal of medicine 2016; (375(17)):1617-1627 doi:10.1056/NEJMoa1604344.
PMID: 27783918
8
Nonpharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-Analysis.
Dobler CC, Morrow AS, Farah MH, et al.
Mayo Clinic proceedings 2020; (95(6)):1169-1183 doi:10.1016/j.mayocp.2020.01.018.
PMID: 32498773
9
Prediction Model of In-Hospital Death for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients Admitted to Intensive Care Unit: The PD-ICU Score.
Li X, Yi Q, Luo Y, et al.
Respiration; international review of thoracic diseases 2025; (104(2)):85-99 doi:10.1159/000541367.
PMID: 39260355
10
A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD.
Hu D, Huang J, Zhao W, et al.
International journal of chronic obstructive pulmonary disease 2024; (19()):139-147 doi:10.2147/COPD.S442715.
PMID: 38249823
11
Supplemental oxygen and noninvasive ventilation.
Owens RL, Derom E, Ambrosino N
European respiratory review : an official journal of the European Respiratory Society 2023; (32(167)) doi:10.1183/16000617.0159-2022.
PMID: 36948502
12
European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD.
Ergan B, Oczkowski S, Rochwerg B, et al.
The European respiratory journal 2019; (54(3)) doi:10.1183/13993003.01003-2019.
PMID: 31467119
13
Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.
Murphy PB, Rehal S, Arbane G, et al.
JAMA 2017; (317(21)):2177-2186 doi:10.1001/jama.2017.4451.
PMID: 28528348
14
Noninvasive positive pressure ventilation in stable patients with COPD.
Wiles SP, Aboussouan LS, Mireles-Cabodevila E
Current opinion in pulmonary medicine 2020; (26(2)):175-185 doi:10.1097/MCP.0000000000000657.
PMID: 31895118
15
Association Between Sarcopenia and Chronic Renal Failure (Overt and Concealed) in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Cross-Sectional Study.
M Y, Dave AK, Patel SS, et al.
Cureus 2023; (15(10)):e46870 doi:10.7759/cureus.46870.
PMID: 37954830
16
Correlation of BODE index with quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients - A prospective study.
Kamath S, Kumar A, Panda SK, Samanta RP
Journal of family medicine and primary care 2020; (9(11)):5606-5613 doi:10.4103/jfmpc.jfmpc_735_20.
PMID: 33532403
17
Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD.
Luo Y, Zhou L, Li Y, et al.
Respiratory care 2016; (61(5)):680-8 doi:10.4187/respcare.04358.
PMID: 26814217
18
The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
Kim J, Lee CH, Hwang SS, et al.
Respiration; international review of thoracic diseases 2019; (98(6)):495-502 doi:10.1159/000502826.
PMID: 31665736
19
Surgical lung volume reduction eligibility in an emphysema patient pool referred for endoscopic treatment.
Vandervelde CM, Hartman JE, Klooster K, et al.
BMC pulmonary medicine 2025; (25(1)):479 doi:10.1186/s12890-025-03954-w.
PMID: 41107777
20
Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.
Davey C, Zoumot Z, Jordan S, et al.
Lancet (London, England) 2015; (386(9998)):1066-73.
PMID: 26116485
21
Lung volume reduction surgery for diffuse emphysema.
van Agteren JE, Carson KV, Tiong LU, Smith BJ
The Cochrane database of systematic reviews 2016; (10()):CD001001 doi:10.1002/14651858.CD001001.pub3.
PMID: 27739074
22
Surgical Approaches to Treating Emphysema: Lung Volume Reduction Surgery, Bullectomy, and Lung Transplantation.
Marchetti N, Criner GJ
Seminars in respiratory and critical care medicine 2015; (36(4)):592-608 doi:10.1055/s-0035-1556064.
PMID: 26238644
23
Bronchoscopic lung volume reduction in emphysema: a review.
Ravikumar N, Wagh A, Holden VK, Hogarth DK
Current opinion in pulmonary medicine 2024; (30(1)):58-67 doi:10.1097/MCP.0000000000001031.
PMID: 37916600
24
Lung Volume Reduction Surgery Before Lung Transplantation: A Propensity-Matched Analysis.
Krishnan A, Chidi A, Merlo CA, et al.
The Annals of thoracic surgery 2022; (113(2)):491-497 doi:10.1016/j.athoracsur.2021.02.009.
PMID: 33609545

This page is for informational purposes only and does not constitute medical advice. Do not change oxygen settings or pursue NIV, surgery, or transplant without guidance from your COPD specialist and care team.

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents